These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

472 related items for PubMed ID: 16310886

  • 1. Randomized multicentric phase II study of carboplatin/gemcitabine and cisplatin/vinorelbine in advanced non-small cell lung cancer GFPC 99-01 study (Groupe français de pneumo-cancérologie).
    Thomas P, Robinet G, Gouva S, Fournel P, Léna H, Le Caer H, Perol M, Berard H, Bombaron P, Vergnenegre A, Kleisbauer JP, Groupe français de pneumo-cancérologie.
    Lung Cancer; 2006 Jan; 51(1):105-14. PubMed ID: 16310886
    [Abstract] [Full Text] [Related]

  • 2. Results of a phase III study of early versus delayed whole brain radiotherapy with concurrent cisplatin and vinorelbine combination in inoperable brain metastasis of non-small-cell lung cancer: Groupe Français de Pneumo-Cancérologie (GFPC) Protocol 95-1.
    Robinet G, Thomas P, Breton JL, Léna H, Gouva S, Dabouis G, Bennouna J, Souquet PJ, Balmes P, Thiberville L, Fournel P, Quoix E, Riou R, Rebattu P, Pérol M, Paillotin D, Mornex F.
    Ann Oncol; 2001 Jan; 12(1):59-67. PubMed ID: 11249050
    [Abstract] [Full Text] [Related]

  • 3. Gemcitabine and cisplatin versus vinorelbine and cisplatin versus ifosfamide+gemcitabine followed by vinorelbine and cisplatin versus vinorelbine and cisplatin followed by ifosfamide and gemcitabine in stage IIIB-IV non small cell lung carcinoma: a prospective randomized phase III trial of the Gruppo Oncologico Italia Meridionale.
    Gebbia V, Galetta D, Caruso M, Verderame F, Pezzella G, Valdesi M, Borsellino N, Pandolfo G, Durini E, Rinaldi M, Loizzi M, Gebbia N, Valenza R, Tirrito ML, Varvara F, Colucci G, Gruppo Ocologico Italia Meridionale.
    Lung Cancer; 2003 Feb; 39(2):179-89. PubMed ID: 12581571
    [Abstract] [Full Text] [Related]

  • 4. Randomized phase II study of carboplatin/gemcitabine versus vinorelbine/gemcitabine in patients with advanced nonsmall cell lung cancer: West Japan Thoracic Oncology Group (WJTOG) 0104.
    Yamamoto N, Nakagawa K, Uejima H, Sugiura T, Takada Y, Negoro S, Matsui K, Kashii T, Takada M, Nakanishi Y, Kato T, Fukuoka M, West Japan Thoracic Oncology Group (WJTOG).
    Cancer; 2006 Aug 01; 107(3):599-605. PubMed ID: 16804877
    [Abstract] [Full Text] [Related]

  • 5. Phase III trial of gemcitabine and carboplatin versus mitomycin, ifosfamide, and cisplatin or mitomycin, vinblastine, and cisplatin in patients with advanced nonsmall cell lung carcinoma.
    Danson S, Middleton MR, O'Byrne KJ, Clemons M, Ranson M, Hassan J, Anderson H, Burt PA, Fairve-Finn C, Stout R, Dowd I, Ashcroft L, Beresford C, Thatcher N.
    Cancer; 2003 Aug 01; 98(3):542-53. PubMed ID: 12879472
    [Abstract] [Full Text] [Related]

  • 6. A randomized phase II trial of sequential gemcitabine plus vinorelbine followed by gemcitabine plus ifosfamide versus gemcitabine plus cisplatin in the treatment of chemo-naive patients with stages III and IV non-small cell lung cancer (NSCLC).
    Grigorescu A, Ciuleanu T, Firoiu E, Muresan DR, Teodorescu G, Basson BR.
    Lung Cancer; 2007 Aug 01; 57(2):168-74. PubMed ID: 17467848
    [Abstract] [Full Text] [Related]

  • 7. A phase I/II trial of induction chemotherapy with carboplatin and gemcitabine followed by concurrent vinorelbine and paclitaxel with chest radiation in patients with stage III non-small cell lung cancer.
    Argiris A, Liptay M, LaCombe M, Marymont M, Kies MS, Sundaresan S, Masters G.
    Lung Cancer; 2004 Aug 01; 45(2):243-53. PubMed ID: 15246197
    [Abstract] [Full Text] [Related]

  • 8. Phase I/II study of gemcitabine and vinorelbine plus cisplatin in non-small cell lung cancer.
    Esteban E, Fra J, Sala M, Carrasco J, Corral N, Vieitez JM, Estrada E, Palacio I, Buesa JM, Lacave AJ.
    Invest New Drugs; 2002 Aug 01; 20(3):317-26. PubMed ID: 12201494
    [Abstract] [Full Text] [Related]

  • 9. Phase II study of PKC-alpha antisense oligonucleotide aprinocarsen in combination with gemcitabine and carboplatin in patients with advanced non-small cell lung cancer.
    Ritch P, Rudin CM, Bitran JD, Edelman MJ, Makalinao A, Irwin D, Lilenbaum R, Peterson P, John WJ.
    Lung Cancer; 2006 May 01; 52(2):173-80. PubMed ID: 16507327
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cisplatin, gemcitabine, and vinorelbine combination therapy in advanced non-small-cell lung cancer: a phase II randomized study of the Southern Italy Cooperative Oncology Group.
    Comella P, Frasci G, Panza N, Manzione L, Lorusso V, Di Rienzo G, Cioffi R, De Cataldis G, Maiorino L, Bilancia D, Nicolella G, Natale M, Carpagnano F, Pacilio C, De Lena M, Bianco A, Comella G.
    J Clin Oncol; 1999 May 01; 17(5):1526-34. PubMed ID: 10334540
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Randomized phase II trial of sequential chemotherapy in advanced non-small cell lung cancer (SWOG 9806): carboplatin/gemcitabine followed by paclitaxel or cisplatin/vinorelbine followed by docetaxel.
    Edelman MJ, Clark JI, Chansky K, Albain K, Bhoopalam N, Weiss GR, Giguere JK, Kelly K, Crowley J, Gandara DR.
    Clin Cancer Res; 2004 Aug 01; 10(15):5022-6. PubMed ID: 15297403
    [Abstract] [Full Text] [Related]

  • 16. Multicenter randomized trial comparing cisplatin-mitomycin-vinorelbine versus cisplatin-mitomycin-vindesine in advanced non-small cell lung cancer. 'Groupe Français de Pneumo-Cancérologie'.
    Pérol M, Guérin JC, Thomas P, Poirier R, Carles P, Robinet G, Kleisbauer JP, Paillotin D, Vergnenègre A, Balmes P, Touron D, Grivaux M, Pham E.
    Lung Cancer; 1996 Feb 01; 14(1):119-34. PubMed ID: 8696715
    [Abstract] [Full Text] [Related]

  • 17. Cisplatin plus gemcitabine versus a cisplatin-based triplet versus nonplatinum sequential doublets in advanced non-small-cell lung cancer: a Spanish Lung Cancer Group phase III randomized trial.
    Alberola V, Camps C, Provencio M, Isla D, Rosell R, Vadell C, Bover I, Ruiz-Casado A, Azagra P, Jiménez U, González-Larriba JL, Diz P, Cardenal F, Artal A, Carrato A, Morales S, Sanchez JJ, de las Peñas R, Felip E, López-Vivanco G, Spanish Lung Cancer Group.
    J Clin Oncol; 2003 Sep 01; 21(17):3207-13. PubMed ID: 12947054
    [Abstract] [Full Text] [Related]

  • 18. A randomized study of gemcitabine plus cisplatin and vinorelbine plus cisplatin in patients with advanced non-small-cell lung cancer.
    Chang JW, Tsao TC, Yang CT, Lin MC, Cheung YC, Liaw CC, Chen CH.
    Chang Gung Med J; 2008 Sep 01; 31(6):559-66. PubMed ID: 19241895
    [Abstract] [Full Text] [Related]

  • 19. Randomized phase 2 study of irinotecan plus cisplatin versus gemcitabine plus vinorelbine as first-line chemotherapy with second-line crossover in patients with advanced nonsmall cell lung cancer.
    Han JY, Lee DH, Song JE, Lee SY, Kim HY, Kim HT, Lee JS.
    Cancer; 2008 Jul 15; 113(2):388-95. PubMed ID: 18484595
    [Abstract] [Full Text] [Related]

  • 20. A randomized phase II trial using two different treatment schedules of gemcitabine and carboplatin in patients with advanced non-small-cell lung cancer.
    Masters GA, Argiris AE, Hahn EA, Beck JT, Rausch PG, Ye Z, Monberg MJ, Bloss LP, Curiel RE, Obasaju CK.
    J Thorac Oncol; 2006 Jan 15; 1(1):19-24. PubMed ID: 17409822
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.